CELUW vs GSK · rev $54.2M vs P/E 13, $103.31B cap
Celularity Inc (CELUW) versus GlaxoSmithKline PLC ADR (GSK) — a side-by-side from cached financials, not a winner call.
Celularity Inc (CELUW) common stock listed on US.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
Latest reported CELUW revenue for 2024-12-31 was $54.2M. Net income was -$57.9M. Revenue was up 138.1% from 2023-12-31 to 2024-12-31. CELUW currently screens at market cap $0.
GSK does not have a complete income-statement cache yet.
CELUW currently screens at market cap $0. GSK currently screens at market cap $103.31B and trailing P/E 13.5.
Not investment advice. Open the CELUW and GSK stock pages for the full models.
Not investment advice.